News

The Almac Group (Almac) has expanded 67,000sft to its Durham facility in North Carolina. Reportedly, the Durham facility comprises the company’s clinical services and diagnostics divisions. The company

Arca biopharma (Arca) has receives FDA Fast Track designation for Gencaro, the company’s investigational, pharmacologically beta-blocker and mild vasodilator. It is intended for the reduction of cardiovascular mortality

Gloster Europe designs and markets an area decontamination technology that provides disinfection of patient environments such as hospital and operating rooms. The technology generates a dry mist of

Asterand has extended its collaboration with Bristol-Myers Squibb for access to the former’s products and services for up to three years. The agreement will focus on access to

Raptor Pharmaceutica (Raptor) has reported positive clinical trial data on NGX426, the company’s orally administered, non-opioid, AMPA/kainate receptor antagonist. The results of the study suggested that NGX426 could

Borealis, a provider of chemical and plastics solutions, will inaugurate its international Innovation Headquarters in Linz, Austria. The total project cost was approximately E50m. About 350 international Borealis

Immunovaccine has entered into an exclusive, worldwide license agreement with Pfizer Animal Health for Immunovaccine’s patented vaccine delivery technology. Pfizer Animal Health has plans to develop enhanced cattle

Victory Pharma (Victory) has launched Naprelan dose card, a further extension of its Naprelan franchise. Naprelan dose card is designed for patients who require relief from mild to

Pfizer has received FDA approval for Geodon (ziprasidone HCI) capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval